GGrantIndex
← Search

Biostatistics, Analytical Support, and Evaluation Shared Resource (BASE SR)

$392,413P30FY2025CANIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications, trials & patents

Trial NCT07339085Trial NCT07276438Trial NCT07242365Trial NCT06650163Trial NCT06568016Trial NCT06113016Trial NCT05595499Trial NCT04205838Trial NCT04201873Trial NCT04185311Trial NCT04119024Trial NCT04106362Trial NCT04069923Trial NCT04069910Trial NCT04050215Trial NCT04007029Trial NCT03996850Trial NCT03970252Trial NCT03953157Trial NCT03904251Trial NCT03902951Trial NCT03892720Trial NCT03830918Trial NCT03825796Trial NCT03745690Trial NCT03732950Trial NCT03732352Trial NCT03672773Trial NCT03623854Trial NCT03618134Trial NCT03603223Trial NCT03601455Trial NCT03596710Trial NCT03582774Trial NCT03582475Trial NCT03541850Trial NCT03515577Trial NCT03506802Trial NCT03425461Trial NCT03411070Trial NCT03368547Trial NCT03319342Trial NCT03240861Trial NCT03202472Trial NCT03128619Trial NCT03025139Trial NCT03014804Trial NCT02940262Trial NCT02928510Trial NCT02925351Trial NCT02919332Trial NCT02902757Trial NCT02888301Trial NCT02881242Trial NCT02880020Trial NCT02879994Trial NCT02830165Trial NCT02816879Trial NCT02775292Trial NCT02756130Trial NCT02701153Trial NCT02688348Trial NCT02683200Trial NCT02672033Trial NCT02597894Trial NCT02575027Trial NCT02451865Trial NCT02336763Trial NCT02310594Trial NCT02296229Trial NCT02280161Trial NCT02263898Trial NCT02176902Trial NCT02070406Trial NCT02049593Trial NCT02048020Trial NCT02015559Trial NCT01912820Trial NCT01013285Trial NCT01005472Trial NCT00999557Trial NCT00998010Trial NCT00985192Trial NCT00955591Trial NCT00882765Trial NCT00880542Trial NCT00769470Trial NCT00706615Trial NCT00685516Trial NCT00616642Trial NCT00612066Trial NCT00601289Trial NCT00601094Trial NCT00521209Trial NCT00509431Trial NCT00471887Trial NCT00450567Trial NCT00444223Trial NCT00352001Trial NCT00349167

Abstract

BIOSTATISTICS, ANALYTICAL SUPPORT AND EVALUATION (BASE) SHARED RESOURCE ABSTRACT The main objective of the UCLA Jonsson Comprehensive Cancer Center (JCCC) Biostatistics, Analytical Support and Evaluation (BASE) Shared Resource (SR) is to provide comprehensive and high-quality biostatistics support for JCCC members’ cancer research. This objective is achieved through three Specific Aims: (1) To provide comprehensive biostatistics support for JCCC investigators in basic, translational, clinical, and population science cancer research; (2) To provide statistics support for the scientific review, implementation, conduct, and monitoring of oncology trials through standing participation on the JCCC Protocol Review and Monitoring Committee (PRMC, locally known as the Internal Scientific Peer Review Committee (ISPRC)) and Data Safety and Monitoring Board (DSMB); and (3) To provide education and training for the next generation of biostatisticians and researchers in cancer research. JCCC members have priority access to BASE SR services, which include, but are not limited to, statistical support for study design, grant applications, data analysis, interpretation of study results, and manuscript preparation. BASE SR also provides essential support for the JCCC ISPRC through rigorous statistical review of JCCC clinical trials protocols and underpins the JCCC DSMB by providing statistical support for the implementation, conduct, and monitoring of JCCC investigator initiated clinical trials. Of note, BASE SR also develops novel statistical methodologies and analytical tools that are responsive to the needs of JCCC researchers and their projects, as discussed in several scientific examples. JCCC oversees BASE SR operations through regular meetings and reporting to JCCC Associate Director for SRs Zoran Galic, PhD (TII). Monthly meetings with Galic and participation in a monthly SR Directors Meeting facilitate bidirectional communications. BASE SR is guided by a four-member Faculty Advisory Committee (FAC) that meets annually. BASE SR actively engages in JCCC activities, including user surveys, annual retreats and symposia, Annual SRs Day, program meetings, and External Advisory Board reviews. This multifaceted approach ensures that BASE SR remains responsive to evolving JCCC researchers’ needs. From 2019 – 2023, 97 JCCC members from all six JCCC Research Programs used BASE SR services, which supported 217 publications, 33% of which were in high impact (IF ≥10) journals. JCCC members account for 80% of total BASE SR usage, and 89% of JCCC member usage was by peer-review funded investigators. BASE SR assists JCCC members with cancer grant applications, which helped secure $51.2M in extramural funding for cancer research. In addition, BASE SR supported 55 cancer clinical trials, with 13 still ongoing. These efforts highlight the pivotal role and essential contribution of BASE SR in advancing current 2019 – 2023 and next period 2024 – 2028 JCCC Strategic Plans and the Center mission to accelerate discoveries to prevent and cure cancer.

View original record on NIH RePORTER →